what are glp-1 receptor agonist medicines agonists promising but unproven treatments for alcohol and substance use disorders Glucagon-like peptide-1 receptor: mechanisms and

The study highlights that after stopping GLP-1 medications, many patients resume treatment or try alternatives, influencing weight management strategies.

not using GLP-1 receptor agonists had significantly lower relative risks for mortality and respiratory failure, according to a presentation at the CHEST Annual Meeting.In a retrospective study, Saud Alawad, MBBS, third-year internal medicine resident at West Virginia University, and colleagues analyzed adults with a group 1 PAH

Here is what patients should know.

These medications enable cause-specific management of obesity complications.

SAN DIEGO(March 10, 2025)Glucagon-like peptide-1 receptor agonists (GLP-1 agonists), such as semaglutide (e.g., Ozempic), have helped improve the management of type 2 diabetes and obesity

Shapely is in-network with Humana for weight loss treatment